|
国际皮肤性病学杂志 2006 32 (2): 117-120 ISSN: 2096-5540 CN: 32-1880/R |
|
|
|
|
|
药物超敏反应综合征发病机制及治疗的研究进展 |
石平荣, 李凯, 段逸群, 周小勇 |
武汉市第一医院皮肤科 430022 |
收稿日期 2005-08-15 修回日期 null 网络版发布日期 null |
参考文献 [1] 橋本公二.DIHSの経緯診斷基凖.医学のあゆみ,2003,205:951. [2] Enomoto M,Ochi M,Teramae K,et al.Codeine phosphate-induced hypersensitivity syndrome.Ann Pharmacother,2004,38:799-802. [3] Mitani N,Aihara M,Yamakawa Y,et al.Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.J Med Virol,2005,75:430-434. [4] Tohyama M,Yahata Y,Yasukawa M,et al.Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.Arch Dermatol,1998,134:1113-1117. [5] Suzuki Y,Inagi R,Aono T,et al.Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.Arch Dermatol,1998,134:1108-1112. [6] Aihara Y,Ito SI,Kobayashi Y,et al.Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction.Br J Dermatol,2003,149:165-169. [7] Hashimoto K,Yasukawa M,Tohyama M.Human herpesvirus 6 and drug allergy.Curr Opin Allergy Clin Immunol,2003,3:255-260. [8] Kano Y,Inaoka M,Sakuma K,et al.Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome.Toxicology,2005,209:165-167. [9] Ohtani T,Hiroi A,Sakurane M,et al.Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine.Br J Dermatol,2003,148:1035-1039. [10] Martin AM,Nolan D,Gaudieri S,et al.Pharmacogenetics of antiretroviral therapy:genetic variation of response and toxicity.Pharmacogenomics,2004,5:643-655. [11] Mallal S,Nolan D,Witt C,et al.Association between presence of HLA-B*5701,HLA-DR7,and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.Lancet,2002,359:727-732. [12] Martin AM,Nolan D,Gaudieri S,et al.Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.Proc Natl Acad Sci U S A,2004,101:4180-4185. [13] Hung SI,Chung WH,Liou LB,et al.HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.Proc Natl Acad Sci U S A,2005,102:4134-4139. [14] Sullivan JR,Shear NH.The drug hypersensitivity syndrome:what is the pathogenesis? Arch Dermatol,2001,137:357-364. [15] Naisbitt DJ,Pirmohamed M,Park BK.Immunopharmacology of hypersensitivity reactions to drugs.Curr Allergy Asthma Rep,2003,3:22-29. [16] Posadas SJ,Padial A,Torres MJ,et al.Delayed reactions to drugs show levels of perforin,granzyme B,and Fas-L to be related to disease severity.J Allergy Clin Immunol,2002,109:155-161. [17] Yawalkar N,Pichler WJ.Immunohistology of drug-induced exanthema:clues to pathogenesis.Curr Opin Allergy Clin Immunol,2001,1:299-303. [18] Shepherd GM.Hypersensitivity reactions to drugs:evaluation and management.Mt Sinai J Med,2003,70:113-125. [19] Kakimoto M,Hasegawa A,Fujita S,et al.Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.J Virol,2002,76:10338-10345. [20] Zou P,Isegawa Y,Nakano K,et al.Human herpesvirus 6 open reading frame U83 encodes a functional chemokine.J Virol,1999,73:5926-5933. [21] Hasegawa A,Yasukawa M,Sakai I,et al.Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.J Immunol,2001,166:1125-1131. [22] Redondo P,de Felipe I,de la Pena A,et al.Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis.Treatment with N-acetylcysteine.Br J Dermatol,1997,136:645-646. [23] 池澤善郎.DIHSやSJS/TENのような重症藥疹の治療と問題點.医学のあゆ,2003,205:965-971. [24] Scheuerman O,Nofech-Moses Y,Rachmel A,et al.Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin.Pediatrics,2001,107:E14. [25] Prins C,Kerdel FA,Padilla RS,et al.Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins:multicenter retrospective analysis of 48 consecutive cases.Arch Dermatol,2003,139:26-32. |
|
|
|
通讯作者: |
|